PROK

1.8 +0.14 (+8.43%)

ProKidney Corp. Class A · NASDAQ

Performance

+8.48%

1W

+18.54%

1M

-9.14%

3M

-15.17%

6M

+5.92%

YTD

+30.66%

1Y

Profile

ProKidney Corp., a clinical-stage biotechnology company, provides transformative proprietary cell therapy platform for treating various chronic kidney diseases. The company's lead product is Renal Autologous Cell Therapy (REACT), an autologous homologous cell admixture that is in Phase I for REACT in patients with Congenital Anomalies of the Kidney and Urinary Tract (CAKUT), as well as in Phase III and Phase II clinical trials for the treatment of moderate to severe diabetic kidney disease. ProKidney Corp. founded in 2015 and is headquartered in Winston-Salem, North Carolina.

Technical Analysis of PROK 2025-01-21

The stock indicators reflect a generally bullish sentiment, with the Moving Average Score at 63 indicating strong upward momentum, while the Oscillators Score of 56 and Technical Score of 60 suggest a neutral to positive outlook. Overall, these scores imply a favorable market environment, though caution may be warranted due to the mixed signals ...
Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

See more ...

Stock Analysis of PROK

Created with Highcharts 11.1.0101077191912120100
QualityGrowthMomentumValue4

Stock Rank

See more ...

Recent News & Updates

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.